To Assess the Efficacy of GP681 Tablet Versus Placebo in Patients With Acute Uncomplicated Influenza Virus Infection

The requested reference [941145d4cb9d86b2b23faf519e019e50a44a26d0] no longer exists in our database. It has been replaced by the current reference: [9857c5f2b192735df3f5707f742b334ba166ad80]

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
This study will evaluate the efficacy, safety, and population pharmacokinetics of a single, oral dose of GP681 compared with placebo in patients aged 12 to 65 years with acute uncomplicated influenza virus infection
Epistemonikos ID: 8b19d0934be8cf738f460b8fb48ca07625ab10d0
First added on: May 13, 2024